NVCR Q2 2018 Earnings — NovoCure Limited Revenue & Financial Results | Market Cap Arena

NVCRNovoCure Limited

$1B

Q2 2018 Earnings

Healthcare Medical - Instruments & Supplies

Income Statement

Revenue

$62M+60.3% YoY

Gross Profit

$42M67.8% margin

Operating Income

-$7M-11.5% margin

Net Income

-$16M-25.2% margin

EPS (Diluted)

$-0.17

QoQ Revenue Growth

+18.0%

Cash Flow

Operating Cash Flow

-$7M

Free Cash Flow

-$9M

Stock-Based Comp.

$10M

Balance Sheet

Total Assets

$310M

Total Liabilities

$198M

Stockholders' Equity

$112M

Cash & Equivalents

$114M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$62M	$38M	+60.3%
Gross Profit	$42M	$25M	+65.2%
Operating Income	-$7M	-$16M	+54.4%
Net Income	-$16M	-$21M	+26.7%

Geographic Segments

UNITED STATES

$42M68%

E M E A

$19M30%

JAPAN

$1M2%